
SAS Certified Statistical Programming Leader with 18+ years of experience supporting global regulatory submissions (FDA, EMA, PMDA) across Phase I–III clinical trials in multiple therapeutic areas including Infectious Disease, Neuroscience, Oncology, Respiratory, Endocrinology, and Rare Disease. Expert in CDISC standards (SDTM, ADaM, Define.xml) and submission readiness, leading programming strategy, CRO oversight, resourcing, and timelines across multiple assets simultaneously. Proven ability to translate complex data challenges into actionable solutions, develop reusable standards and automation tools, and drive efficiency through Agile practices and AI-assisted programming. Experienced in cross-functional collaboration, audit/inspection readiness, CAPA implementation, and mentoring teams to deliver high-quality results under tight timelines.
Acting as Asset Lead for ID, HIV Projects with multiple studies overseeing all clinical programming activities.